Hanover THG Q1 2026 Beat Revenue NA EPS Exceeds by Significant Alaunos Therapeutics TCRT Unchanged at 250 RangeBound Trading 20260520 Adamas Trust ADAMO Stock Is It a Good Market Opportunity ADAMO Latest Quarter Earnings Adamas Trust has no EPS or revenue data for period NVO Novo posts slight Q4 2025 earnings beat and 64 year over year revenue growth shares edge lower DTW DTE2077Bond posts 72 Q4 2025 EPS beat shares climb 075 on positive investor sentiment Bilibili BILI Stock Risks and Rewards Momentum Fading 20260420 CreativeMed CELZ Volatility Analysis Q3 2025 Profit Surprises